KR102025446B1 - 프로필라그린 c 말단 도메인 특이적 항체 및 그의 용도 - Google Patents

프로필라그린 c 말단 도메인 특이적 항체 및 그의 용도 Download PDF

Info

Publication number
KR102025446B1
KR102025446B1 KR1020147011999A KR20147011999A KR102025446B1 KR 102025446 B1 KR102025446 B1 KR 102025446B1 KR 1020147011999 A KR1020147011999 A KR 1020147011999A KR 20147011999 A KR20147011999 A KR 20147011999A KR 102025446 B1 KR102025446 B1 KR 102025446B1
Authority
KR
South Korea
Prior art keywords
terminal domain
gene
propyllagrin
abnormality
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020147011999A
Other languages
English (en)
Korean (ko)
Other versions
KR20140089366A (ko
Inventor
도시히코 히비노
마미 야마모토
마사야 다카기
준이치 사카베
요시키 도쿠라
Original Assignee
가부시키가이샤 시세이도
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가부시키가이샤 시세이도 filed Critical 가부시키가이샤 시세이도
Publication of KR20140089366A publication Critical patent/KR20140089366A/ko
Application granted granted Critical
Publication of KR102025446B1 publication Critical patent/KR102025446B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020147011999A 2011-11-09 2012-11-08 프로필라그린 c 말단 도메인 특이적 항체 및 그의 용도 Expired - Fee Related KR102025446B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2011-245483 2011-11-09
JP2011245483A JP5771123B2 (ja) 2011-11-09 2011-11-09 プロフィラグリンｃ末端ドメイン特異的抗体及びその用途
PCT/JP2012/079015 WO2013069741A1 (ja) 2011-11-09 2012-11-08 プロフィラグリンc末端ドメイン特異的抗体及びその用途

Publications (2)

Publication Number Publication Date
KR20140089366A KR20140089366A (ko) 2014-07-14
KR102025446B1 true KR102025446B1 (ko) 2019-09-25

Family

ID=48290111

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147011999A Expired - Fee Related KR102025446B1 (ko) 2011-11-09 2012-11-08 프로필라그린 c 말단 도메인 특이적 항체 및 그의 용도

Country Status (7)

Country Link
US (2) US20140287431A1 (enExample)
EP (1) EP2778174B1 (enExample)
JP (1) JP5771123B2 (enExample)
KR (1) KR102025446B1 (enExample)
CN (1) CN104039827B (enExample)
ES (1) ES2650733T3 (enExample)
WO (1) WO2013069741A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2020076770A1 (en) * 2018-10-08 2020-04-16 Yale University Selective binding and aggregation of human keratin in the skin barrier using human filaggrin subdomains sd67 and sd150

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE511116T1 (de) * 1991-04-26 1993-04-29 Clonatec S.A., Paris Antigene, die von polyarthritis rheumatoide antikoerpern erkannt werden, ihre herstellung und ihre anwendungen.
WO2006009805A2 (en) * 2004-06-18 2006-01-26 Genentech, Inc. Combination of a chemotherapeutic agent and an antagonist of a gene product for treating tumors
GB0525492D0 (en) * 2005-12-15 2006-01-25 Univ Dundee Filaggrin
JP2007217325A (ja) * 2006-02-16 2007-08-30 Kose Corp プロフィラグリン及び／又はフィラグリン産生促進剤
ES2541614T3 (es) * 2009-12-03 2015-07-22 Shiseido Company, Ltd. Método de selección de agentes que mejoran la piel seca asociada con la dermatitis atópica empleando la actividad de bleomicina hidrolasa como medida

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Experimental Dermatology. 2010, 19(8):e343-346.*
NCBI database. profilaggrin, partial[Homo sapiens], GenBank: AAA63248.1(1995.03.07.)*

Also Published As

Publication number Publication date
WO2013069741A1 (ja) 2013-05-16
CN104039827A (zh) 2014-09-10
HK1201856A1 (en) 2015-09-11
JP5771123B2 (ja) 2015-08-26
EP2778174A4 (en) 2015-06-24
US20190079080A1 (en) 2019-03-14
EP2778174B1 (en) 2017-11-01
JP2013100249A (ja) 2013-05-23
EP2778174A1 (en) 2014-09-17
ES2650733T3 (es) 2018-01-22
CN104039827B (zh) 2016-12-14
KR20140089366A (ko) 2014-07-14
US20140287431A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
US5585344A (en) Liver-derived receptors for advanced glycosylation endproducts and uses thereof
EP0218531A2 (en) Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
CN113683702B (zh) 条纹斑竹鲨单域抗体的多克隆抗体的制备方法及其应用
Schauer-Vukasinovic et al. Human napsin A: expression, immunochemical detection, and tissue localization
JP6232618B2 (ja) ヒト汗中に含まれる新規ヒスタミン遊離物質
KR102025446B1 (ko) 프로필라그린 c 말단 도메인 특이적 항체 및 그의 용도
Christner et al. Specificity of the binding interaction between human serum amyloid P-component and immobilized human C-reactive protein
RU2662973C2 (ru) Пептидомиметики
Abréu Vélez et al. The tryptic cleavage product of the mature form of the bovine desmoglein I ectodomain is one of the antigen moieties immunoprecipitated by all sera from symptomatic patients affected by a new variant of endemic pemphigus
RU2739607C2 (ru) Специфически очищенные антитела против пресепсина
CN110437326B (zh) 大疱性类天疱疮BP230 IgE抗体的抗原表位多肽及其用途
JP3271159B2 (ja) レニン活性物質
Moritz et al. Micro-sequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epithelium
JP5943945B2 (ja) プロフィラグリンｃ末端ドメイン特異的抗体及びその用途
JPWO2007145192A1 (ja) Ｉｖ型コラーゲン様免疫活性ペプチド
JP2648952B2 (ja) 種々の病理的状態に於いてｐｓ２遺伝子から特異的に発現される蛋白質及びその断片、該蛋白質及び／又はその断片から得られる抗体、並びに病理的状態に対する検出、診断及び治療への該蛋白質、その断片及び抗体の適用
AU616195B2 (en) Lectines fixing beta-d-galactoside
KR20120005891A (ko) 유비퀴틴 특이적 프로테아제 44（ｕｓｐ４４）의 에피토프 펩타이드 및 이의 이용
JP2915530B2 (ja) ラミニン フラグメント
Hanssens et al. Measurement of individual angiotensin peptides by HPLC-RIA
TWI316604B (en) A method for evaluating a hair growth promoting activity
HK1201856B (en) Antibody specific to profilaggrin c-terminal domain, and use thereof
EP1423708B1 (fr) Compositions et methodes pour le dosage de l'aa4rp
JP2006117594A (ja) 活性型カスパーゼ−１４特異的抗体及びその作成方法
JP2011190202A (ja) サポシンａ特異的抗体及びその作成方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20220920

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20220920